A senior NHS leader at the centre of a growing conflict-of-interest debate is stepping down from his position, after revelations about his advisory role with US technology firm Palantir Technologies.
Matthew Swindells, who has served as joint chair of four major hospital trusts in north-west London since 2022, is understood to be leaving his NHS role following scrutiny over his links to the company behind the NHS’s Federated Data Platform (FDP). The development comes amid wider concerns about governance, transparency and the relationship between senior NHS leaders and private technology suppliers, particularly in relation to large-scale data programmes.
Dual roles raise conflict-of-interest questions
The controversy centres on Swindells’ dual roles within the NHS and the private sector. While acting as a senior NHS figure, he also advised Palantir through the lobbying and consultancy firm Global Counsel, which has since collapsed. Reports revealed that in 2024 he encouraged colleagues to consider expanding the use of patient data within the FDP, Palantir’s flagship NHS data platform, despite formal requirements for him to recuse himself from decisions involving the company.
In one communication, Swindells suggested that patient-level data could be integrated into the platform to support “automated workflows”, raising concerns among some colleagues about governance and data protection implications. Although Swindells has maintained that his proposals were not implemented and related to local systems rather than the national platform, the episode has intensified debate about how conflicts of interest are managed within NHS leadership structures.
The Federated Data Platform and its wider implications
At the heart of the issue is the NHS Federated Data Platform, a £330 million programme awarded to Palantir in 2023. The platform is designed to integrate operational data across the health service, including waiting lists, staffing and treatment information, with the aim of improving efficiency and decision-making. The FDP is one of the most ambitious digital infrastructure projects undertaken by the NHS, forming a key part of its broader push towards data-driven healthcare.
However, it has also been highly controversial. Critics, including clinicians, unions and privacy groups have raised concerns about data security, patient consent and the potential for misuse of sensitive information. The Swindells case has amplified these concerns, highlighting the complexity of managing relationships between public sector leaders and private technology firms in an era of rapid digital transformation.
Growing scrutiny of NHS–tech sector relationships
The situation reflects a broader trend of increasing scrutiny over the so-called “revolving door” between the NHS and the technology sector. Swindells, a former deputy chief executive of NHS England, has long been a prominent figure in health system leadership and digital transformation. His move into advisory roles following his departure from national NHS leadership is not unusual, but the overlap with his subsequent NHS chair position has raised questions about governance standards.
Experts have argued that existing rules, such as declarations of interest and recusal requirements, may not be sufficient to maintain public trust, particularly when large-scale data contracts are involved. The controversy has also reignited debate about procurement processes for digital platforms, with some stakeholders calling for stronger oversight and clearer separation between public decision-making and private sector influence.
Technology, trust and the future of NHS data strategy
From a health technology perspective, the episode underscores the challenges of implementing large-scale digital transformation programmes in a highly regulated and publicly accountable system. The NHS is increasingly reliant on advanced data platforms, analytics tools and artificial intelligence to manage demand and improve patient outcomes. Partnerships with private technology companies are therefore likely to play a central role in future service delivery.
However, maintaining public trust will be critical. Concerns about data privacy, transparency and accountability have the potential to slow adoption and create resistance among both staff and patients. The Swindells case illustrates how governance issues can intersect with technological innovation, highlighting the need for robust frameworks that ensure ethical use of data while enabling innovation.
A defining moment for NHS digital governance
As Swindells prepares to step down, the episode is likely to have lasting implications for NHS leadership and digital policy. It may prompt a review of conflict-of-interest rules, particularly for senior figures involved in major technology programmes. It could also influence how future contracts are structured and overseen, with greater emphasis on transparency and accountability.
For the health technology sector, the case serves as a reminder that technical capability alone is not enough. Trust, governance and ethical standards are equally critical in shaping the success of digital transformation. As the NHS continues its shift towards data-driven care, balancing innovation with public confidence will remain one of its most pressing challenges.
